Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt.

Background: Immunocompromised patients face reactivation of latent viruses that increase the risk of morbidity.

Aim: The study aimed to detect human herpes virus 6 (HHV-6) reactivation among allogeneic (allo) and autologous (auto) hematopoietic stem cell transplant (HSCT) recipients and to correlate potentially attributed clinical manifestations to HHV-6 DNA plasma level.

Methods: A prospective study included all (forty) patients undergoing allo and auto-HSCT from Jan 2020 till June 2022.

Study of Patterns and Markers of Human Immune Deficiency Virus -1 (HIV-1) Progression and Unemployment Rate among Patients from Alexandria, Egypt.

Middle East and North Africa (MENA) new HIV cases show the highest increase among all regions in the world. Even though Egypt has a low prevalence among the general population (< 0.02%), a national HIV epidemic occurs in certain population risk groups.